Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,994 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Splicing factor deficits render hematopoietic stem and progenitor cells sensitive to STAT3 inhibition.
Potts KS, Cameron RC, Metidji A, Ghazale N, Wallace L, Leal-Cervantes AI, Palumbo R, Barajas JM, Gupta V, Aluri S, Pradhan K, Myers JA, McKinstry M, Bai X, Choudhary GS, Shastri A, Verma A, Obeng EA, Bowman TV. Potts KS, et al. Among authors: verma a. Cell Rep. 2022 Dec 13;41(11):111825. doi: 10.1016/j.celrep.2022.111825. Cell Rep. 2022. PMID: 36516770 Free PMC article.
Improving Unrelated Donor Equity: Assessing Mismatched Donor Opportunities with Real-World Data in a Minority-Predominant Cohort.
Hammami MB, Verceles JA, Goldfinger M, Shah N, Sica RA, Mantzaris I, Kornblum N, Konopleva M, Shastri A, Shapiro LC, Feldman EJ, Gritsman K, Verma A, Cooper DL. Hammami MB, et al. Among authors: verma a. Transplant Cell Ther. 2024 May;30(5):544.e1-544.e8. doi: 10.1016/j.jtct.2024.02.020. Epub 2024 Feb 28. Transplant Cell Ther. 2024. PMID: 38417677
A STAT3 Degrader Demonstrates Pre-clinical Efficacy in Venetoclax resistant Acute Myeloid Leukemia.
Chakraborty S, Morganti C, Pena BR, Zhang H, Verma D, Zaldana K, Gitego N, Ma F, Aluri S, Pradhan K, Gordon S, Mantzaris I, Goldfinger M, Feldman E, Gritsman K, Shi Y, Hubner S, Qiu YH, Brown BD, Skwarska A, Verma A, Konopleva M, Tabe Y, Gavathiotis E, Colla S, Gollob J, Dey J, Kornblau SM, Koralov SB, Ito K, Shastri A. Chakraborty S, et al. Among authors: verma d, verma a. bioRxiv [Preprint]. 2024 Aug 7:2024.08.05.599788. doi: 10.1101/2024.08.05.599788. bioRxiv. 2024. PMID: 39211137 Free PMC article. Preprint.
High Dose Cyclophosphamide for the Treatment of Severe Immune Checkpoint Inhibitor Related Adverse Events.
Davis T, Fedorov K, Gregos PS, Shapiro LC, Shastri A, Gritsman K, Shah N, Sica RA, Konopleva M, Feldman E, Mantzaris I, Braunschweig I, Verma A, Cooper D, Kornblum N, Goldfinger M. Davis T, et al. Among authors: verma a. J Oncol Res Ther. 2023;8(4):10194. doi: 10.29011/2574-710x.10194. Epub 2023 Dec 20. J Oncol Res Ther. 2023. PMID: 39371330 Free PMC article.
A germline FLT3 variant in aplastic anemia.
Amaeshi LC, Sofianidi AA, Shastri A, Goldfinger M, Konopleva M, Verma AK, Chaitowitz M, Mantzaris I. Amaeshi LC, et al. Among authors: verma ak. Biomark Res. 2025 Jan 7;13(1):4. doi: 10.1186/s40364-024-00717-3. Biomark Res. 2025. PMID: 39773519 Free PMC article.
Transcription elongation defects link oncogenic SF3B1 mutations to targetable alterations in chromatin landscape.
Boddu PC, Gupta AK, Roy R, De La Peña Avalos B, Olazabal-Herrero A, Neuenkirchen N, Zimmer JT, Chandhok NS, King D, Nannya Y, Ogawa S, Lin H, Simon MD, Dray E, Kupfer GM, Verma A, Neugebauer KM, Pillai MM. Boddu PC, et al. Among authors: verma a. Mol Cell. 2024 Apr 18;84(8):1475-1495.e18. doi: 10.1016/j.molcel.2024.02.032. Epub 2024 Mar 22. Mol Cell. 2024. PMID: 38521065
Socio-demographic determinants of myelofibrosis outcomes in an underserved center and the SEER national database.
Yan J, Hammami MB, Wei JX, Shah N, Goldfinger M, Mantzaris I, Kornblum N, Gritsman K, Sica A, Cooper D, Feldman E, Konopleva M, Pradhan K, Thakur R, Vegivinti C, Qasim A, Verma A, Goel S. Yan J, et al. Among authors: verma a. Ann Hematol. 2024 Sep;103(9):3543-3551. doi: 10.1007/s00277-024-05894-7. Epub 2024 Jul 24. Ann Hematol. 2024. PMID: 39046510 Free PMC article.
A Co-Management Model for Myeloid Malignancies That Evolved during the COVID-19 Pandemic.
Goradia N, Shastri A, Verma A, Feldman E, Cooper D, Konopleva M, Fox S, Gritsman K, Shah N, Mantzaris I, Braunschweig I, Kornblum N, Sica A, Levitz D, Comas M, Goldfinger M. Goradia N, et al. Among authors: verma a. Acta Haematol. 2023;146(2):144-150. doi: 10.1159/000527982. Epub 2022 Nov 29. Acta Haematol. 2023. PMID: 36446346 Free PMC article.
Pharmacological restriction of genomic binding sites redirects PU.1 pioneer transcription factor activity.
Taylor SJ, Stauber J, Bohorquez O, Tatsumi G, Kumari R, Chakraborty J, Bartholdy BA, Schwenger E, Sundaravel S, Farahat AA, Wheat JC, Goldfinger M, Verma A, Kumar A, Boykin DW, Stengel KR, Poon GMK, Steidl U. Taylor SJ, et al. Among authors: verma a. Nat Genet. 2024 Oct;56(10):2213-2227. doi: 10.1038/s41588-024-01911-7. Epub 2024 Sep 18. Nat Genet. 2024. PMID: 39294495 Free PMC article.
5,994 results